Editing RNA to understand and combat COVID-19
CRISPR-based editing of RNA and cellular mechanisms that govern RNA repair
['FUNDING_OTHER'] · UNIVERSITY OF FLORIDA · NIH-11080122
This study is exploring how to use a special technology called CRISPR to change the RNA of the COVID-19 virus, which could help us understand how the virus works and find new ways to treat or prevent the illness.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11080122 on ClinicalTrials.gov |
What this research studies
This research focuses on using CRISPR technology to edit RNA, particularly in the context of the SARS-CoV-2 virus responsible for COVID-19. The project aims to uncover the mechanisms of RNA repair and develop new tools for RNA editing that could enhance our understanding of viral replication and host interactions. By targeting specific regions of the viral genome, the researchers hope to identify how the virus manipulates host cell responses and to test the effects of these modifications on viral behavior. This work could lead to innovative strategies for treating or preventing COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by COVID-19 or those at high risk for severe outcomes from the virus.
Not a fit: Patients who are not affected by COVID-19 or do not have underlying health conditions related to the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for COVID-19 and improve our understanding of viral infections.
How similar studies have performed: Other research has shown promise in using CRISPR technology for gene editing, but the specific application to RNA repair in the context of COVID-19 is relatively novel.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NEMUDRYI, ARTEM ALEKSANDROVICH — UNIVERSITY OF FLORIDA
- Study coordinator: NEMUDRYI, ARTEM ALEKSANDROVICH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.